Itau Unibanco Holding S.A.’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,641
Closed -$81K 463
2020
Q1
$81K Sell
9,641
-26,312
-73% -$222K 0.01% 152
2019
Q4
$351K Buy
+35,953
New +$338K 0.02% 131
2019
Q3
Sell
-46,829
Closed -$556K 709
2019
Q2
$556K Buy
+46,829
New +$564K 0.03% 238
2018
Q3
Sell
-10,181
Closed -$162K 813
2018
Q2
$162K Buy
+10,181
New +$152K 0.02% 388

Other funds holding VIVO

Itau Unibanco Holding S.A.'s VIVO Position: Q2 2020 in Review

Itau Unibanco Holding S.A. sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 9,641 shares — an estimated $81K sold.

Itau Unibanco Holding S.A. first reported a position in VIVO in Q2 2018 and held it in 4 quarters. The position peaked at $556K in Q2 2019. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

  • Itau Unibanco Holding S.A. reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 9,641 Meridian Bioscience Inc shares in Q2 2020, an estimated $81K.
  • Itau Unibanco Holding S.A. first reported a position in Meridian Bioscience Inc in Q2 2018 and held it in 4 quarters.
  • Itau Unibanco Holding S.A.'s Meridian Bioscience Inc position peaked at $556K in Q2 2019.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2020, filed 14 Aug 2020.